Home › Funds › Affinity Asset Advisors, LLC › ERAS

Affinity Asset Advisors, LLC position in ERAS

ERASCA INC · Health Care

Affinity Asset Advisors, LLC reported holding 5,590,600 shares of ERAS (ERASCA INC) in its Q3 2026 13F filing — a position valued at US$82.0M, representing 3.82% of its reported portfolio and ranking #5 among its reported holdings. Affinity Asset Advisors, LLC has disclosed ERAS holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)5.59M sh
Reported value held$81.96M
Portfolio Weight3.82%
First reportedQ2 2024
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Affinity Asset Advisors, LLC's ERAS position evolved

Affinity Asset Advisors, LLC first disclosed a stake in ERAS in Q2 2024 at 2,499,431 shares (US$5.9M). The position peaked in Q2 2026 at 5,250,000 shares, worth US$96.2M. Across 10 filings, Affinity Asset Advisors, LLC increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 5,590,600 shares valued at US$82.0M — an increase of 340,600 shares quarter over quarter.. Notable position changes include a 34% increase in Q1 2025 (shares fell 7% over the following quarter), a 37% increase in Q1 2026 (shares rose 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 2.50M $5.90M New
Q3 2024 2.50M $6.82M Hold
Q4 2024 2.50M $6.27M Hold
Q1 2025 3.34M $4.58M Add
Q2 2025 4.09M $5.19M Add
Q3 2025 4.29M $9.34M Add
Q4 2025 3.90M $14.51M Reduce
Q1 2026 5.35M $86.56M Add
Q2 2026 5.25M $96.18M Reduce
Q3 2026 5.59M $81.96M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ERAS and 13F data

ERAS (ERASCA INC) is a Health Care company. 73 other funds we track also report a position in ERAS — the largest reported positions include Frazier Life Sciences Management, L.P. (US$457.5M), RTW INVESTMENTS, LP (US$328.8M), Venrock Adviser, LLC (US$327.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ERAS

All ERAS fund holders →

FAQ

How long has Affinity Asset Advisors, LLC held ERAS?

Affinity Asset Advisors, LLC has disclosed ERAS holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is Affinity Asset Advisors, LLC's current position in ERAS?

As of Q3 2026, Affinity Asset Advisors, LLC holds 5.59M shares of ERAS (ERASCA INC), valued at $81.96M, representing 3.82% of its reported portfolio and ranking #5.

Has Affinity Asset Advisors, LLC been buying or selling ERAS?

In the latest 13F filing (Q3 2026), Affinity Asset Advisors, LLC increased its position in ERAS. The position peaked in Q2 2026 at 5.25M shares.

Which other funds hold ERAS?

Other major institutional holders of ERAS include Frazier Life Sciences Management, L.P., RTW INVESTMENTS, LP, Venrock Adviser, LLC, among 73 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.